Literature DB >> 22828333

Weak interactions govern the viscosity of concentrated antibody solutions: high-throughput analysis using the diffusion interaction parameter.

Brian D Connolly1, Chris Petry, Sandeep Yadav, Barthélemy Demeule, Natalie Ciaccio, Jamie M R Moore, Steven J Shire, Yatin R Gokarn.   

Abstract

Weak protein-protein interactions are thought to modulate the viscoelastic properties of concentrated antibody solutions. Predicting the viscoelastic behavior of concentrated antibodies from their dilute solution behavior is of significant interest and remains a challenge. Here, we show that the diffusion interaction parameter (k(D)), a component of the osmotic second virial coefficient (B(2)) that is amenable to high-throughput measurement in dilute solutions, correlates well with the viscosity of concentrated monoclonal antibody (mAb) solutions. We measured the k(D) of 29 different mAbs (IgG(1) and IgG(4)) in four different solvent conditions (low and high ion normality) and found a linear dependence between k(D) and the exponential coefficient that describes the viscosity concentration profiles (|R| ≥ 0.9). Through experimentally measured effective charge measurements, under low ion normality where the electroviscous effect can dominate, we show that the mAb solution viscosity is poorly correlated with the mAb net charge (|R| ≤ 0.6). With this large data set, our results provide compelling evidence in support of weak intermolecular interactions, in contrast to the notion that the electroviscous effect is important in governing the viscoelastic behavior of concentrated mAb solutions. Our approach is particularly applicable as a screening tool for selecting mAbs with desirable viscosity properties early during lead candidate selection.
Copyright © 2012 Biophysical Society. Published by Elsevier Inc. All rights reserved.

Mesh:

Substances:

Year:  2012        PMID: 22828333      PMCID: PMC3388210          DOI: 10.1016/j.bpj.2012.04.047

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  30 in total

1.  Direct measurement of protein osmotic second virial cross coefficients by cross-interaction chromatography.

Authors:  Peter M Tessier; Stanley I Sandler; Abraham M Lenhoff
Journal:  Protein Sci       Date:  2004-04-09       Impact factor: 6.725

2.  Factors affecting the viscosity in high concentration solutions of different monoclonal antibodies.

Authors:  Sandeep Yadav; Steven J Shire; Devendra S Kalonia
Journal:  J Pharm Sci       Date:  2010-12       Impact factor: 3.534

Review 3.  Colloidal behavior of proteins: effects of the second virial coefficient on solubility, crystallization and aggregation of proteins in aqueous solution.

Authors:  Joseph J Valente; Robert W Payne; Mark Cornell Manning; W William Wilson; Charles S Henry
Journal:  Curr Pharm Biotechnol       Date:  2005-12       Impact factor: 2.837

4.  Molecular origins of osmotic second virial coefficients of proteins.

Authors:  B L Neal; D Asthagiri; A M Lenhoff
Journal:  Biophys J       Date:  1998-11       Impact factor: 4.033

5.  Viscosity analysis of high concentration bovine serum albumin aqueous solutions.

Authors:  Sandeep Yadav; Steven J Shire; Devendra S Kalonia
Journal:  Pharm Res       Date:  2011-04-14       Impact factor: 4.200

6.  Behavior of monoclonal antibodies: relation between the second virial coefficient (B (2)) at low concentrations and aggregation propensity and viscosity at high concentrations.

Authors:  Shuntaro Saito; Jun Hasegawa; Naoki Kobayashi; Naoyuki Kishi; Susumu Uchiyama; Kiichi Fukui
Journal:  Pharm Res       Date:  2011-08-19       Impact factor: 4.200

7.  A convenient small osmometer.

Authors:  B H ZIMM; I MYERSON
Journal:  J Am Chem Soc       Date:  1946-05       Impact factor: 15.419

8.  The concentration-dependence of macromolecular parameters.

Authors:  S E Harding; P Johnson
Journal:  Biochem J       Date:  1985-11-01       Impact factor: 3.857

9.  Understanding and modulating opalescence and viscosity in a monoclonal antibody formulation.

Authors:  Branden A Salinas; Hasige A Sathish; Steven M Bishop; Nick Harn; John F Carpenter; Theodore W Randolph
Journal:  J Pharm Sci       Date:  2010-01       Impact factor: 3.534

Review 10.  Sickle cell anemia, the first molecular disease: overview of molecular etiology, pathophysiology, and therapeutic approaches.

Authors:  Martin H Steinberg
Journal:  ScientificWorldJournal       Date:  2008-12-25
View more
  67 in total

1.  Viscosity Analysis of Dual Variable Domain Immunoglobulin Protein Solutions: Role of Size, Electroviscous Effect and Protein-Protein Interactions.

Authors:  Ashlesha S Raut; Devendra S Kalonia
Journal:  Pharm Res       Date:  2015-08-19       Impact factor: 4.200

Review 2.  Molecular basis of high viscosity in concentrated antibody solutions: Strategies for high concentration drug product development.

Authors:  Dheeraj S Tomar; Sandeep Kumar; Satish K Singh; Sumit Goswami; Li Li
Journal:  MAbs       Date:  2016-01-06       Impact factor: 5.857

Review 3.  Advances in Antibody Design.

Authors:  Kathryn E Tiller; Peter M Tessier
Journal:  Annu Rev Biomed Eng       Date:  2015-08-14       Impact factor: 9.590

4.  High throughput detection of antibody self-interaction by bio-layer interferometry.

Authors:  Tingwan Sun; Felicia Reid; Yuqi Liu; Yuan Cao; Patricia Estep; Claire Nauman; Yingda Xu
Journal:  MAbs       Date:  2013-08-19       Impact factor: 5.857

5.  The limitations of an exclusively colloidal view of protein solution hydrodynamics and rheology.

Authors:  Prasad S Sarangapani; Steven D Hudson; Kalman B Migler; Jai A Pathak
Journal:  Biophys J       Date:  2013-11-19       Impact factor: 4.033

6.  In silico selection of therapeutic antibodies for development: viscosity, clearance, and chemical stability.

Authors:  Vikas K Sharma; Thomas W Patapoff; Bruce Kabakoff; Satyan Pai; Eric Hilario; Boyan Zhang; Charlene Li; Oleg Borisov; Robert F Kelley; Ilya Chorny; Joe Z Zhou; Ken A Dill; Trevor E Swartz
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-15       Impact factor: 11.205

7.  Quantitative Correlation between Viscosity of Concentrated MAb Solutions and Particle Size Parameters Obtained from Small-Angle X-ray Scattering.

Authors:  Masakazu Fukuda; Chifumi Moriyama; Tadao Yamazaki; Yoshimi Imaeda; Akiko Koga
Journal:  Pharm Res       Date:  2015-06-16       Impact factor: 4.200

8.  A novel screening method to assess developability of antibody-like molecules.

Authors:  Neeraj Kohli; Nidhi Jain; Melissa L Geddie; Maja Razlog; Lihui Xu; Alexey A Lugovskoy
Journal:  MAbs       Date:  2015       Impact factor: 5.857

Review 9.  Assessment and significance of protein-protein interactions during development of protein biopharmaceuticals.

Authors:  Sandeep Yadav; Jun Liu; Thomas M Scherer; Yatin Gokarn; Barthélemy Demeule; Sonoko Kanai; James D Andya; Steven J Shire
Journal:  Biophys Rev       Date:  2013-03-14

10.  Charge-mediated Fab-Fc interactions in an IgG1 antibody induce reversible self-association, cluster formation, and elevated viscosity.

Authors:  Jayant Arora; Yue Hu; Reza Esfandiary; Hasige A Sathish; Steven M Bishop; Sangeeta B Joshi; C Russell Middaugh; David B Volkin; David D Weis
Journal:  MAbs       Date:  2016-08-25       Impact factor: 5.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.